Angel Biotechnology Holdings plc, (AIM: ABH) the biopharmaceutical contract manufacturer, is delighted to announce that it has been awarded a Licence to manufacture Investigational Medicinal Products (IMPs) to Good Manufacturing Practices (GMPs) at its new state-of-the-art manufacturing facility in Cramlington. The Licence was granted at the end of August following a successful inspection by the UK Medicines and Heathcare products Regulatory Agency (MHRA). The inspection focussed on Angel's Quality systems and GMPs and found them to be compliant with the EU Clinical Trials Directive (2001/20/EU). This licence is a mandatory requirement for operating the facility to GMP in compliance with the directive.
